MedTrace Logo

CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT

NCT03015285 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2024-08-21

No results posted yet for this study

Summary

Adults with high anxiety sensitivity (AS) and a mental health diagnosis of anxiety, depression, or posttraumatic stress will be recruited and will be randomly assigned to either transdiagnostic cognitive behavioural therapy (CBT) for AS or disorder-specific CBT for their primary mental health problem. The study outcomes - AS, anxiety, mood, and substance use symptoms, and functional impairment - will be assessed at pre-and post-treatment and 6 and 12 months post-treatment via standardized self-report measures completed by participants and a standardized diagnostic interview.

Conditions

  • Generalized Anxiety
  • Stress Disorder, Posttraumatic
  • Social Anxiety
  • Major Depression
  • Panic Disorder

Interventions

BEHAVIORAL

Cognitive Behavioural Therapy

A type of talk therapy called cognitive behaviour therapy (CBT) will be delivered to both groups.

Sponsors & Collaborators

  • University of New Brunswick

    collaborator OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Dalhousie University

    collaborator OTHER

  • Nova Scotia Health Authority

    lead OTHER

Principal Investigators

  • Margo Watt, PhD · St. Francis Xavier University

  • Janine Olthuis, PhD · University of New Brunswick

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-05
Primary Completion
2022-02-18
Completion
2022-02-18

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03015285 on ClinicalTrials.gov